

[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
Tara Bancroft Initiated (BCYC) at Buy on, Aug 31st, 2022
Tara Bancroft of Cowen & Co., Initiated "Bicycle Therapeutics plc" (BCYC) at Buy on, Aug 31st, 2022.
Tara has made no other calls on BCYC in the last 4 months.
There are 5 other peers that have a rating on BCYC. Out of the 5 peers that are also analyzing BCYC, 0 agree with Tara's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Tara
- Jonathan Chang of "SVB Leerink" Maintained at Buy with Increased Target to $50 on, Monday, August 22nd, 2022
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $57 on, Friday, August 5th, 2022
- Peter Lawson of "Barclays" Initiated at Buy and Held Target at $30 on, Thursday, July 28th, 2022
- William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $60 on, Wednesday, July 6th, 2022
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Monday, May 23rd, 2022
Contributing Sources